相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study
Michael Hardy et al.
THROMBOSIS RESEARCH (2021)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann et al.
ANNALS OF INTERNAL MEDICINE (2020)
COVID19 coagulopathy in Caucasian patients
Helen Fogarty et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2
Albert Huisman et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Marco Cattaneo et al.
THROMBOSIS AND HAEMOSTASIS (2020)
ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients
R. Escher et al.
THROMBOSIS RESEARCH (2020)
Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity
Mitchell R. Dyer et al.
TRANSFUSION (2020)
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
Christopher M. Petrilli et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Songping Cui et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients
Mario Bazzan et al.
INTERNAL AND EMERGENCY MEDICINE (2020)
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
George Goshua et al.
LANCET HAEMATOLOGY (2020)
Endothelial cells orchestrate COVID-19 coagulopathy Comment
Jamie M. O'Sullivan et al.
LANCET HAEMATOLOGY (2020)
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation
Annabel Blasi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink
Nuccia Morici et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Severe COVID-19 infection associated with endothelial activation
Robert Escher et al.
THROMBOSIS RESEARCH (2020)
The coagulopathy, endotheliopathy, and vasculitis of COVID-19
Toshiaki Iba et al.
INFLAMMATION RESEARCH (2020)
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Girish N. Nadkarni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
Upendra K. Katneni et al.
THROMBOSIS AND HAEMOSTASIS (2020)
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19
Nicola Martinelli et al.
THROMBOSIS RESEARCH (2020)
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
Aravinthan Varatharaj et al.
LANCET PSYCHIATRY (2020)
Identification of cysteine thiol-based linkages in ADAMTS13 in support of a non-proteolytic regulation of von Willebrand factor
Hanspeter Rottensteiner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
ADAMTS-13 and von Willebrand factor: a dynamic duo
K. South et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH
K. Suzuki et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
Marie Scully et al.
BLOOD (2017)
Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial
Pier Mannuccio Mannucci et al.
BLOOD (2013)
Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies
B. Plaimauer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Multi-step binding of ADAMTS-13 to von Willebrand factor
H. B. Feys et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Severe Plasmodium falciparum Malaria Is Associated with Circulating Ultra-Large von Willebrand Multimers and ADAMTS13 Inhibition
Deirdre Larkin et al.
PLOS PATHOGENS (2009)
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells
W. J. Cao et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity
Seiji Kato et al.
TRANSFUSION (2006)
Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA)
M Rieger et al.
THROMBOSIS AND HAEMOSTASIS (2006)
FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay
K Kokame et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation
RA Reiter et al.
THROMBOSIS AND HAEMOSTASIS (2005)
VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13
K Kokame et al.
BLOOD (2004)
Variations among normal individuals in the cleavage endothelial-derived ultra-large von Willebrand factor under flow
JF Dong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow
A Bernardo et al.
BLOOD (2004)
ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions
JF Dong et al.
BLOOD (2002)
Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13)
B Plaimauer et al.
BLOOD (2002)
分享论文
